Changes in Inflammatory Biomarkers in Patients Treated With Ticagrelor or Clopidogrel

BACKGROUND: Inflammation is a key factor in the development of atherosclerotic disease and acute coronary syndromes (ACS). The P2Y(12) receptor antagonists ticagrelor (AZD6140) and clopidogrel may have anti‐inflammatory effects. The objective of this analysis from the Dose Confirmation Study Assessi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Husted, Steen, Storey, Robert F., Harrington, Robert A., Emanuelsson, Håkan, Cannon, Christopher P.
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2010
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6653411/
https://ncbi.nlm.nih.gov/pubmed/20394040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20732
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados